Study proposes ‘liquid-biopsy-like’ alternative to determine cardiometabolic risk in in patients living with obesity

Obesity levels worldwide are rising and therefore, personalized care is becoming paramount. At the same time, scientists believe that not all fat is the same. Previous studies have shown that measuring levels of visceral adipose tissue (VAT) inflammation gives a good approximation of cardiometabolic risk. However, currently VAT inflammation cannot be measured without invasive surgery.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup